EPCLUSA (sofosbuvir and velpatasvir) tablets is used for the treatment of patients with chronic (long-lasting) hepatitis C, a viral infection of the liver.

EPCLUSA is a fixed-dose combination of sofosbuvir, a hepatitis C virus (HCV) nucleotide analog NS5B polymerase inhibitor, and velpatasvir, an HCV NS5A inhibitor, and is indicated for the treatment of adult patients with chronic HCV genotype 1, 2, 3, 4, 5, or 6 infection : • without cirrhosis or with compensated cirrhosis • with decompensated cirrhosis for use in combination with ribavirin

EPCLUSA (sofosbuvir and velpatasvir) tablets suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of EPCLUSA (sofosbuvir and velpatasvir) tablets brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the EPCLUSA (sofosbuvir and velpatasvir) tablets medicine cost price in India.

The order for EPCLUSA (sofosbuvir and velpatasvir) tablets will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Sofosbuvir/velpatasvir, is a fixed dose combination medication for the treatment of hepatitis C. It combines sofosbuvir and velpatasvir. It is more than 90% effective for hepatitis C genotypes one through six. It also works for hepatitis C in those who also have cirrhosis or HIV/AIDS.

EPCLUSA (sofosbuvir and velpatasvir) tablets, for oral use Initial U.S. Approval: 2016

Generic Name: sofosbuvir and velpatasvir

Tablets: 400 mg sofosbuvir and 100 mg velpatasvir

EPCLUSA (sofosbuvir and velpatasvir) tablets

EPCLUSA (sofosbuvir and velpatasvir) tablets is available.

Get In Touch

Indian Pharma Network (IPN), Delhi. India

IPN, Delhi are legitimate consultant and facilitator in India, group of highly qualified pharma professionals. Specialized in Oncology and other pharma products. Helped more than 6,000 patients. Registration Number: 07AAFFI2544E1ZO under GST Act. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India. IPN, New Delhi helps patient to get access of anti cancer medicines which is not available in India.

Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Saudi Arabia | South Africa

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex,
Yusuf Sarai, New Delhi, Delhi 110016

Mobile / WhatsApp / Phone

M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support


EPCLUSA (sofosbuvir and velpatasvir) tablets suppliers in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand EPCLUSA (sofosbuvir and velpatasvir) tablets on prescription and Import License in Patient's Name only.

For overseas patients, EPCLUSA (sofosbuvir and velpatasvir) tablets can be made available in Send your enquiry to find EPCLUSA (sofosbuvir and velpatasvir) tablets in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

News / Update for EPCLUSA (sofosbuvir and velpatasvir) tablets.

For EPCLUSA (sofosbuvir and velpatasvir) tablets Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

GERD and the Elderly Patient: Clinical Considerations For More Details

Profile of sofosbuvir/velpatasvir/voxilaprevir in the treatment of hepatitis C For More Details

Sofosbuvir/Velpatasvir for HCV Treatment in Patients Undergoing Dialysis For More Details

Get Access To FDA Approved Drug EPCLUSA (sofosbuvir and velpatasvir) tablets In India

Indian Pharma Network (IPN), Delhi India is a leading Pharmaceutical Distributor / Supplier / Exporter / Importer of Anti-Cancer Medicines, used in Hepatitis C Virus treatment. Brand Name "EPCLUSA (sofosbuvir and velpatasvir) tablets" or Generic Name "sofosbuvir and velpatasvir tablets" can be imported for personal use under "patient name basis" treatment in Delhi, Noida, Gurgaon, Mumbai, Chennai, Kolkatta, Bangalore, Jaipur, Chandigarh India. Contact us at urgent@indianpharmanetwork.co.in or call/WhatsApp at +91 9891296838 / 9811747774 to get access as per norms.